ArticleJournal of the National Cancer Institute2020

Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls.

Yukihide Momozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.